Document Detail


Effects of beta-hydroxy-beta-methylbutyrate on muscle damage after a prolonged run.
MedLine Citation:
PMID:  11007567     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study examined the effects of supplemental beta-hydroxy-beta-methylbutyrate (HMB) on muscle damage as a result of intense endurance exercise. Subjects (n = 13) were paired according to their 2-mile run times and past running experience. Each pair was randomly assigned a treatment of either HMB (3 g/day) or a placebo. After 6 wk of daily training and supplementation, all subjects participated in a prolonged run (20-km course). Creatine phosphokinase and lactate dehydrogenase (LDH) activities were measured before and after a prolonged run to assess muscle damage. The placebo-supplemented group exhibited a significantly greater (treatment main effect, P = 0.05) increase in creatine phosphokinase activity after a prolonged run than did the HMB-supplemented group. In addition, LDH activity was significantly lower (treatment main effect, P = 0.003) with HMB supplementation compared with the placebo-supplemented group. In conclusion, supplementation with 3.0 g of HMB results in a decreased creatine phosphokinase and LDH response after a prolonged run. These findings support the hypothesis that HMB supplementation helps prevent exercise-induced muscle damage.
Authors:
A E Knitter; L Panton; J A Rathmacher; A Petersen; R Sharp
Related Documents :
18373287 - Lower limb kinematics of subjects with chronic achilles tendon injury during running.
8558627 - Running intensity as determined by heart rate is the same in fast and slow runners in b...
18810107 - Effectiveness of foot orthotic devices used to modify pronation in runners*.
1788497 - Exercise-entrained breathing and non-invasive determination of anaerobic threshold.
14767257 - Effect of frequency of carbohydrate feedings on recovery and subsequent endurance run.
8925847 - Assessing neuroreceptor occupancy by continuous infusion of carbon-11 labeled radioliga...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Journal of applied physiology (Bethesda, Md. : 1985)     Volume:  89     ISSN:  8750-7587     ISO Abbreviation:  J. Appl. Physiol.     Publication Date:  2000 Oct 
Date Detail:
Created Date:  2000-10-25     Completed Date:  2000-11-09     Revised Date:  2013-09-26    
Medline Journal Info:
Nlm Unique ID:  8502536     Medline TA:  J Appl Physiol (1985)     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1340-4     Citation Subset:  IM    
Affiliation:
Human Performance Laboratory, Iowa State University, Ames, Iowa 50011, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Body Composition
Creatine Kinase / blood
Dietary Supplements
Female
Humans
L-Lactate Dehydrogenase / blood
Male
Middle Aged
Muscle, Skeletal / drug effects*,  physiology,  physiopathology
Oxygen Consumption / drug effects*
Placebos
Running / physiology*
Valerates / administration & dosage,  blood,  pharmacology*
Chemical
Reg. No./Substance:
0/Placebos; 0/Valerates; 3F752311CD/beta-hydroxyisovaleric acid; EC 1.1.1.27/L-Lactate Dehydrogenase; EC 2.7.3.2/Creatine Kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neurocirculatory consequences of intermittent asphyxia in humans.
Next Document:  No evidence for long-term facilitation after episodic hypoxia in spontaneously breathing, anesthetiz...